.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
Deloitte
US Army
Farmers Insurance
Citi
Federal Trade Commission
UBS
Dow
QuintilesIMS
McKinsey

Generated: June 27, 2017

DrugPatentWatch Database Preview

KHEDEZLA Drug Profile

« Back to Dashboard

Which patents cover Khedezla, and what generic Khedezla alternatives are available?

Khedezla is a drug marketed by Osmotica Pharm Corp and is included in one NDA.

The generic ingredient in KHEDEZLA is desvenlafaxine. There are sixteen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the desvenlafaxine profile page.

Summary for Tradename: KHEDEZLA

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list2
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:KHEDEZLA at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Osmotica Pharm Corp
KHEDEZLA
desvenlafaxine
TABLET, EXTENDED RELEASE;ORAL204683-001Jul 10, 2013BCRXNoNo► Subscribe► Subscribe
Osmotica Pharm Corp
KHEDEZLA
desvenlafaxine
TABLET, EXTENDED RELEASE;ORAL204683-002Jul 10, 2013BCRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Boehringer Ingelheim
Merck
Dow
Cerilliant
Deloitte
Moodys
Queensland Health
Fish and Richardson
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot